Diiodothyropropionic acid
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2004 (NCT00032643)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 3,5-diiodothyropropionic acid
- 3,5-diiodothyropropionic acid
- 3,5-diiodothyropropionic acid
- 3,5-diiodothyropropionic acid
- 3,5-ditpa
- benzenepropanoic acid, 4-(4-hydroxyphenoxy)-3,5-diiodo-
- diiodothyropropionic acid
- ditpa
- ditpa
- ditpa cpd
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00311987 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2006 | Johns Hopkins University |
| NCT00103519 | Phase 2 | Dec 1, 2004 | The University of Texas, Dallas, Titan Pharmaceuticals |
| NCT00032643 | Phase 2 | Jun 1, 2004 | Department of Veteran Affairs |
| NCT04143295 | N/A | — | University of Miami |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Veteran Affairs | Government | 1 | 1 | 1 | 2004 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Titan Pharmaceuticals | For profit | 1 | 1 | 1 | 2004 |
| University of Miami | Academic/Hospital | 1 | 1 | 1 | — |
5 organizations
Page 1 / 1